Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation
Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation Anders Molven 1 , Guri E. Matre 1 , Marinus Duran 2 , Ronald J. Wanders 2 , Unni Rishaug 3 , Pål R. Njølstad 1 4 , Egil Jellum 5 and Oddmund Søvik 4 1 Center for Medical Genetics and M...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 53; no. 1; pp. 221 - 227 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.01.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation
Anders Molven 1 ,
Guri E. Matre 1 ,
Marinus Duran 2 ,
Ronald J. Wanders 2 ,
Unni Rishaug 3 ,
Pål R. Njølstad 1 4 ,
Egil Jellum 5 and
Oddmund Søvik 4
1 Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
2 Laboratory for Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlands
3 Department of Endocrinology, Aker University Hospital, Oslo, Norway
4 Institute for Clinical Medicine and Molecular Medicine, Department of Pediatrics, University of Bergen, Bergen, Norway
5 Institute of Clinical Biochemistry, National Hospital, Oslo, Norway
Address correspondence and reprint requests to Prof. Anders Molven, Department of Pathology, The Gade Institute, Haukeland
University Hospital, University of Bergen, N-5021 Bergen, Norway. E-mail: anders.molven{at}gades.uib.no
Abstract
Inappropriately elevated insulin secretion is the hallmark of persistent hyperinsulinemic hypoglycemia of infancy (PHHI),
also denoted congenital hyperinsulinism. Causal mutations have been uncovered in genes coding for the β-cell’s ATP-sensitive
potassium channel and the metabolic enzymes glucokinase and glutamate dehydrogenase. In addition, one hyperinsulinemic infant
was recently found to have a mutation in the gene encoding short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), an enzyme
participating in mitochondrial fatty acid oxidation. We have studied a consanguineous family with severe neonatal hypoglycemia
due to increased insulin levels and where well-established genetic causes of hyperinsulinism had been eliminated. A genome-wide,
microsatellite-based screen for homozygous chromosomal segments was performed. Those regions that were inherited in accordance
with the presupposed model were searched for mutations in genes encoding metabolic enzymes. A novel, homozygous deletion mutation
was found in the gene coding for the SCHAD enzyme. The mutation affected RNA splicing and was predicted to lead to a protein
lacking 30 amino acids. The observations at the molecular level were confirmed by demonstrating greatly reduced SCHAD activity
in the patients’ fibroblasts and enhanced levels of 3-hydroxybutyryl-carnitine in their blood plasma. Urine metabolite analysis
showed that SCHAD deficiency resulted in specific excretion of 3-hydroxyglutaric acid. By the genetic explanation of our family’s
cases of severe hypoglycemia, it is now clear that recessively inherited SCHAD deficiency can result in PHHI. This finding
suggests that mitochondrial fatty acid oxidation influences insulin secretion by a hitherto unknown mechanism.
MIM, Mendelian Inheritance in Man
PHHI, persistent hyperinsulinemic hypoglycemia of infancy
SCHAD, short-chain 3-hydroxyacyl-CoA dehydrogenase
Footnotes
Accepted October 10, 2003.
Received August 29, 2003.
DIABETES |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.53.1.221 |